Atripla vs. Viracept: side effect and effectiveness comparison (a real world drug study)

Summary:

We compare the side effects and drug effectiveness of Atripla and Viracept. The phase IV clinical study is created by eHealthMe based on reports (from sources including the FDA) of 46,042 people who take Atripla and Viracept, and is updated regularly.

What is Atripla?

Atripla has active ingredients of efavirenz; emtricitabine; tenofovir disoproxil fumarate. It is often used in hiv infection. eHealthMe is studying from 36,036 Atripla users. Check the latest studies of Atripla.

What is Viracept?

Viracept has active ingredients of nelfinavir mesylate. It is often used in hiv infection. eHealthMe is studying from 6,399 Viracept users. Check the latest studies of Viracept.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.



On Aug, 30, 2026

46,042 people who take Atripla and Viracept are studied.

Atripla vs Viracept drug comparison reports.

Drugs being compared in this study:

  • Viracept (nelfinavir mesylate)
  • Atripla (efavirenz; emtricitabine; tenofovir disoproxil fumarate)

Most common side effects of the drugs, overall:

Click here to view

Most common side effects of the drugs, in long term (1+ years) use:

Click here to view

Drug effectiveness:

Atripla:

  • not at all: 2.09 %
  • somewhat: 3.88 %
  • moderate: 12.24 %
  • high: 25.97 %
  • very high: 55.82 %

Viracept:

  • not at all: 0 %
  • somewhat: 0 %
  • moderate: 20 %
  • high: 40 %
  • very high: 40 %

Want to compare Atripla with Viracept?

- Personalize this study to your gender and age (0-99+)

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.



Related studies

Alternative drugs to, pros and cons of:

Browse all side effects of Atripla:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Viracept:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study is based on efavirenz; emtricitabine; tenofovir disoproxil fumarate and nelfinavir mesylate (the active ingredients of Atripla and Viracept, respectively). Other drugs that have the same active ingredients (e.g. generic drugs or brand names) are also considered. Dosage of drugs is not considered in the study.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: